Provided by Tiger Trade Technology Pte. Ltd.

Insulet

134.68
-3.2400-2.35%
Post-market: 134.800.1172+0.09%19:44 EDT
Volume:1.87M
Turnover:252.27M
Market Cap:9.33B
PE:25.43
High:138.66
Open:136.74
Low:134.11
Close:137.92
52wk High:354.88
52wk Low:126.40
Shares:69.26M
Float Shares:69.07M
Volume Ratio:1.22
T/O Rate:2.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.30
EPS(LYR):3.48
ROE:26.02%
ROA:9.71%
PB:6.56
PE(LYR):38.71

Loading ...

Insulet Device Correction Seen as Setback, Long-Term Targets Intact, RBC Says

MT Newswires Live
·
May 28

Movement Alert|Insulet Falls 6.74% in Regular Trading, Voluntary Omnipod Device Correction Expected to Cost Up to $50 Million

Market Focus
·
May 28

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
May 28

BUZZ-U.S. STOCKS ON THE MOVEd-Micron, Abercrombie & Fitch, Q32 Bio

Reuters
·
May 27

Insulet Shares Down 4.4% Premarket After Flagging Defect in Some Insulin Pods

THOMSON REUTERS
·
May 27

Analysts’ Top Healthcare Picks: Alnylam Pharma (ALNY), Insulet (PODD)

TIPRANKS
·
May 27

Insulet Is Maintained at Buy by BTIG

Dow Jones
·
May 27

Goldman Sachs Adjusts Price Target on Insulet to $205 From $237, Maintains Buy Rating

MT Newswires Live
·
May 27

U.S. RESEARCH ROUNDUP- Agilent Technologies, Fedex, Synopsys

Reuters
·
May 27

Insulet Narrows Legal Path As Delaware Forum Rule Meets Share Pressure

Simply Wall St.
·
May 27

Insulet price target lowered to $235 from $260 at BTIG

TIPRANKS
·
May 27

Stocks to Watch: Zscaler, Verra Mobility, Digital Turbine, Insulet

Dow Jones
·
May 27

Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost

Reuters
·
May 27

Insulet Flags Manufacturing Issue Affecting 7M Insulin Pods

Dow Jones
·
May 27

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipods

MT Newswires Live
·
May 27

Insulet initiates voluntary medical device correction for certain Omnipod lots

TIPRANKS
·
May 27

Insulet Corp - Does Not Expect Impact to Long-Term Growth Profile or 2026 Guidance - SEC Filing

THOMSON REUTERS
·
May 27

Insulet Corp - Expects up to $50 Mln of Costs in 2026 Due to Device Correction, Excluded From Adj Results - SEC Filing

THOMSON REUTERS
·
May 27

Insulet Corp - Does Not Anticipate Disruption to Shipments, Product Availability, or New Customer Starts - SEC Filing

THOMSON REUTERS
·
May 27

Insulet starts correction for 7 million Omnipod insulin pump pods over under-delivery risk

Reuters
·
May 27